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Hypothermia in paediatric  
traumatic brain injury: cons
Bernhard Frey
Introduction
During the last 10 years, the number of cases of 
 severe traumatic brain injury (TBI) admitted to the 
paediatric intensive care unit (PICU) of the Children’s 
Hospital in Zurich has decreased, most probably 
 owing to the success of preventive measures, such as 
helmets or stricter speed limits for cars (fig. 1). The 
mortality of patients with TBI admitted to our PICU 
for the last 10 years was 5.4% (22/166) (fig. 1). The 
 management of children with severe TBI starts at 
the scene, and continues during transport and in the 
admitting shock room, before the patient is treated 
in the PICU. Shock room management is crucial. 
There must be strict guidelines for the functions of 
each member of the interdisciplinary shock room 
team, especially with regard to the continuously 
changing compositions of these teams [1]. For the 
management in PICU, we use the “Swiss guidelines 
for the treatment of severe traumatic brain injury in 
children” [2]. The basic measures are: normo- 
oxygenation, normo-capnia, normo-volaemia / blood 
pressure, normal Na
+
 concentration, sedation / anal-
gesia and head up 30°. With an intracranial pressure 
(ICP) transducer in place, the neurointensive care is 
ICP- and cerebral perfusion pressure(CPP)-driven, 
with additional measures added in an escalating 
manner to keep ICP and CPP in the normal range: 
mannitol, noradrenaline, cerebrospinal fluid vent-
ing, hypothermia (32–34 °C), barbiturate coma, 
hyper ventilation (if paCO
2
 <4 kPa: monitoring of 
SO
2
 in the bulbus jugularis is mandatory) and, as a 
last resort, decompressive craniectomy. 
Hypothermia as neuroprotective  
treatment
There is much debate as to whether hypothermia 
may be used not only to lower ICP, but also as 
 neuroprotective treatment modality. The biological 
rational for the effectiveness of therapeutic hypo-
thermia is the reduction of secondary injury through 
decreased cerebral metabolic demands, decreased in-
flammation, decreased lipid peroxidation, decreased 
excitotoxicity and decreased cell death. There is good 
evidence for therapeutic hypothermia in perinatal 
asphyxia [3] and in cardiac arrest in adults [4]. How-
ever, to date, there is no evidence in paediatric TBI. 
A survey of eight PICUs in Switzerland revealed that 
only one unit uses hypothermia as neuroprotective 
treatment in severe TBI, the other units keep the 
 patients normothermic [5]. 
There is good evidence for therapeutic hypothermia as neuroprotective treat-
ment in perinatal asphyxia and in cardiac arrest in adults. However, to date, 
there is no evidence in paediatric traumatic brain injury (TBI). A meta-analysis 
of four randomised controlled trials of hypothermia in  severe paediatric TBI 
 revealed a non significant higher risk of mortality with hypothermia (risk ratio 
1.45, 95% confidence interval 0.71–2.94). These patients should be kept normo-
thermic (36–37°C). Hypothermia may be occasionally used to lower increased 
 intracranial pressure, but arterial hypotension in the rewarming period must 
be avoided. 
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Randomised trials of hypothermia  
for children with severe traumatic  
brain injury
There are four randomised controlled trials (RCTs) of 
hypothermia for children with severe TBI [6, 7, 8, 9]. 
In all these trials, severe TBI is defined as a low 
 Glasgow Coma Scale (GCS) score of <8 or <8.
The first trial was published in 2002 by Biswas et al. 
[6]. This single centre RCT compared hypothermia 
with normothermia in 21 children. There was no 
 significant difference in mortality and functional 
outcome at 3, 6 and 12 months after TBI. During hypo-
thermia, ICP was lower and CPP was higher, but after 
hypothermia (in the rewarming period), CPP was 
lower compared with the normothermia group.
Adelson et al. performed two multicentre RCTs [7, 8]. 
The first was a phase II study with a focus on safety, 
mortality and complications of hypothermia [7]. 
 Hypothermia was maintained for 48 hours and 
 rewarming speed was 1 °C every 3 to 4 hours. Twenty- 
three patients were in the hypothermia group (32–
33 °C) and 24 patients in the normothermia group. 
Mortality and complications, such as arrhythmias, 
infections and coagulopathy, were not significantly 
different between the two groups. Again, in the hypo-
thermia group there was decreased mean ICP during 
hypothermia, but increased (rebound) ICP during 
 rewarming.
The largest multicentre RCT so far was published 
in 2008 by Hutchison et al. [9]. Data sampling took 
place between 1999 and 2004. The primary outcome 
measure was the proportion of patients with an unfa-
vourable outcome at 6 months after injury (severe 
disability, persistent vegetative state or death). In 
the hypothermia group, a mean (standard devia-
tion) temperature of 32.5 °C (0.5 °C) was aimed for, 
for 24 hours, with a rewarming speed of 0.5 °C every 
2 hours. There were 108 children in the hypothermia 
group and 117 children in the normothermia group. 
There was no significant difference for the primary 
outcome measure (unfavourable outcome): hypo-
thermia 31%, normothermia 22% (p = 0.14). There 
were more deaths in the hypothermia group (21% vs 
14%, p = 0.06). Long-term visual memory at 12 months 
after trauma was worse in the hypothermia group 
(p = 0.05). And again, as in the previous two studies, 
ICP was lower during cooling, but higher during 
 rewarming. This study was heavily criticised: (1.) 
start of hypothermia was too late (the mean time 
to initiation of cooling was 6.3 hours) in view of 
the fact that neuronal death occurs a few hours af-
ter injury; (2.) duration of hypothermia (24 hours) 
was too short, in view of the occurrence of peak 
brain oedema  between 24 and 48 hours after injury; 
(3.) rewarming was too fast, leading to rebound 
 intracranial hypertension; (4.) the hypothermia 
group was worse (more patients with midline shift, 
oedema, hypotension and hypoxia); (5.) the normo-
thermia group received better treatment (more 
 patients with hypertonic  saline) and (6.) there were 
more episodes of arterial hypotension and low CPP in 
Figure 1: Children with traumatic brain injury in the paediatric intensive care unit of the University Children’s Hospital Zurich, 
2004–2013: total number, number of ventilated patients and deaths.
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the hypothermia group. In fact, the same authors 
published a post-hoc analysis of their data two 
years later and showed that  arterial hypotension and 
low CPP were significantly associated with unfavour-
able outcome (in both intervention groups) [10]. The 
vulnerability of the brain to hypotension may be 
 related to loss of autoregulation and vulnerability to 
cerebral ischaemia [11].
The second study of Adelson et al. [8], a phase III 
 multicentre RCT, aimed to improve on the critical 
points of the Hutchison study: starting cooling ear-
lier (<6 hours after injury), cooling for a longer period 
(48 hours or even longer), rewarming more slowly 
and aggressively avoiding hypotension (especially in 
the rewarming period) with administration of fluids 
and pressors. The primary outcome in this study was 
mortality at 3 months. Importantly, very severe cases 
were excluded (GCS score 3, unreactive pupils, severe 
arterial hypotension and uncorrectable coagulo-
pathy). Randomisation was aimed to take place at less 
than 6 hours after injury. There was rapid cooling 
 (initially with iced saline) to 32–33 °C, for 48 hours 
(if high ICP at 48 hours: further 24 hours of cooling) 
and slow rewarming (0.5–1 °C every 12–24 hours). 
 Emphasis was put on avoiding hypotension, hypoxia 
and intracranial hypertension. The planned sample 
size was 340, but the trial was stopped early after 
 futility analysis, with 39 hypothermia patients and 
38 normothermia patients. The mean time to initia-
tion of cooling was 5 hours, that is, within the target 
of 6 hours. Mortality at 3 months was not different 
(hypothermia 15%, normothermia 5%, p = 0.15). There 
were more patients with decompressive craniectomy 
in the normothermia group (p = 0.02), possibly to the 
advantage of these patients. 
Conclusion
A meta-analysis of the four RCTs of hypothermia 
in severe paediatric TBI revealed a nonsignificant 
higher risk of mortality with hypothermia (risk ratio 
1.45, 95% confidence interval 0.71–2.94) [12]. The mean 
time to starting cooling (4.6–6.3 hours) and the tar-
get temperature (three studies: 32–33 °C, one study 
32–34 °C) were not very different between the four 
 trials. However, the duration of cooling and the 
 rewarming times were quite different, as was tem-
perature variation during hypothermia (in the study 
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of Biswas et al. [6], there was wide variation of 
 temperatures). Although there was some variability 
between these trials, none showed a positive effect of 
hypothermia on mortality and some (gross and 
early) functional outcome measures. Further studies 
with alternative designs, taking into account the cir-
cumstances, such as cooling temperature, timing, 
and injury type, may reveal efficacy of this treatment 
modality [8]. In fact, it is very difficult to keep the 
multitude of  interventions constant in therapeutic 
TBI trials. At least, hyperthermia should be pre-
vented in severe childhood TBI. These patients 
should be kept normothermic (36–37 °C). Hypother-
mia may be occasionally used to lower increased ICP, 
but arterial hypotension must be avoided. 
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